Source link : https://www.newshealth.biz/health-news/ema-recommends-seladelpar-for-primary-biliary-cholangitis/
The European Medicines Agency (EMA) has recommended granting marketing authorization for Seladelpar Gilead (seladelpar lysine dihydrate) to treat primary biliary cholangitis (PBC). PBC is a chronic autoimmune liver disease marked by inflammation and progressive destruction of the small bile ducts within the liver. This leads to the accumulation of toxic bile acids, potentially progressing to […]
Author : News Health
Publish date : 2024-12-13 14:50:19
Copyright for syndicated content belongs to the linked Source.